MK-8245
| CAS No. | 1030612-87-3 | Cat. No. | BCP06568 |
| Name | MK-8245 | ||
| Synonyms | MK 8245;MK8245; | ||
| Formula | C16H15BrFN7O3S | M. Wt | 484.3 |
| Description | MK-8245 is a potent, liver-targeted SCD inhibitor with preclinical antidiabetic and antidyslipidemic efficacy with a significantly improved therapeutic window. MK-8245 was believed to inhibit the SCD enzyme solely in the liver and not in other tissues for the following reasons. When SCD inhibition has been measured by desaturation index in tissues of rodents treated with MK-8245, the desaturation index was significantly reduced in liver but not in other tissues such as skin, eye and adipose tissue. | ||
| Pathways | Protease/Metabolic Enzyme | ||
| Targets | SCD | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.